First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784

Update Il y a 4 ans
Reference: NCT02212080

Woman Man

  • | Country :
  • Germany
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study is a first in human study that will investigate the safety, tolerability and pharmacokinetics of ascending single doses of BAY1214784 using a placebo controlled, randomized, single center design. In addition the bioavailability of two different liquid formulations will be compared.


Inclusion criteria

  • Clinical Trials, Phase I as Topic

Links